A detailed history of Citigroup Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Citigroup Inc holds 82,030 shares of TNDM stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,030
Previous 109,674 25.21%
Holding current value
$3.04 Million
Previous $4.42 Million 21.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$35.21 - $47.3 $973,345 - $1.31 Million
-27,644 Reduced 25.21%
82,030 $3.48 Million
Q2 2024

Aug 12, 2024

BUY
$30.43 - $53.43 $999,047 - $1.75 Million
32,831 Added 42.72%
109,674 $4.42 Million
Q1 2024

May 10, 2024

BUY
$22.09 - $35.41 $748,077 - $1.2 Million
33,865 Added 78.8%
76,843 $2.72 Million
Q4 2023

Feb 09, 2024

BUY
$14.28 - $31.03 $189,138 - $410,992
13,245 Added 44.55%
42,978 $1.27 Million
Q3 2023

Nov 09, 2023

SELL
$19.33 - $36.22 $53,331 - $99,930
-2,759 Reduced 8.49%
29,733 $617,000
Q2 2023

Aug 10, 2023

BUY
$24.18 - $42.46 $59,966 - $105,300
2,480 Added 8.26%
32,492 $797,000
Q1 2023

May 11, 2023

BUY
$35.86 - $46.5 $730,826 - $947,670
20,380 Added 211.59%
30,012 $1.22 Million
Q4 2022

Feb 09, 2023

SELL
$35.49 - $56.15 $276,289 - $437,127
-7,785 Reduced 44.7%
9,632 $432,000
Q3 2022

Nov 10, 2022

SELL
$43.76 - $68.97 $713,112 - $1.12 Million
-16,296 Reduced 48.34%
17,417 $833,000
Q2 2022

Aug 10, 2022

SELL
$53.22 - $123.09 $94,678 - $218,977
-1,779 Reduced 5.01%
33,713 $2 Million
Q1 2022

May 12, 2022

SELL
$101.89 - $150.09 $916,806 - $1.35 Million
-8,998 Reduced 20.22%
35,492 $4.13 Million
Q4 2021

Feb 10, 2022

SELL
$118.18 - $153.21 $1.17 Million - $1.52 Million
-9,907 Reduced 18.21%
44,490 $6.7 Million
Q3 2021

Nov 10, 2021

BUY
$93.51 - $129.4 $5.09 Million - $7.04 Million
54,397 New
54,397 $6.49 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.